EU approves J&J purchase of Actelion subject to conditions

Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

BRUSSELS (Reuters) – EU antitrust regulators approved on Friday Johnson & Johnson’s planned purchase of Actelion Pharmaceutical subject to conditions intended to ensure clinical development of insomnia drugs were unaffected.